Studies have pointed out that nicotine has certain anti-inflammatory effects and also binds to angiotensin converting enzyme 2 cell membrane proteins, downregulating the expression of nasal angiotensin converting enzyme 2 and other receptors for novel coronavirus infection, which in turn reduces the risk of COVID-19 and provides a certain protective effect [40–43]. Here, ACE2 is linked to COVID-19.